Nakajima et al
Several factors can contribute, including metabolic adaptations and lifestyle inconsistencies
The GLP-1 agonists, according to a new big piece in The Economist, may well become the next watershed moment in pharmaceutical history
Instead, providers typically consider a combination of factors before recommending any further increase, including how well a patient tolerated the previous stage, whether appetite and metabolic markers are trending in the expected direction, and whether any side effects reported at the current stage have resolved
Non-drug RLS treatments may include hot baths, heating pads or ice packs applied to the legs, good sleeping habits and leg massages
This is known as Post-Lyme Disease Syndrome and does not respond to additional antibiotic courses